Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(5 sites)

Austria

Medizinische Universität Wien, Vienna, State of Vienna

France

Necker-Enfants Malades Hospital, Paris, Paris, Paris

Hungary

Gottsegen National Cardiovascular Center, Budapest, Budapest

Slovakia

Pediatric Cardiac Center, Bratislava

Spain

Ramón y Cajal University Hospital, Madrid, Madrid